当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › BMC Cancer杂志
BMC Cancer
基本信息
期刊名称 BMC Cancer
BMC CANCER
期刊ISSN 1471-2407
期刊官方网站 https://bmccancer.biomedcentral.com
是否OA Yes
出版商 BioMed Central Ltd
出版周期 Irregular
文章处理费 登录后查看
始发年份 2001
年文章数 1227
影响因子 3.4(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 ONCOLOGY 肿瘤学3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 6.0 1.087 0.944
Medicine
Oncology
127/404 68%
Biochemistry, Genetics and Molecular Biology
Genetics
131/347 62%
Biochemistry, Genetics and Molecular Biology
Cancer Research
105/230 54%
补充信息
自引率 2.9%
H-index 111
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1471-2407%5BISSN%5D
投稿指南
期刊投稿网址 https://author-welcome.nature.com/12885
收稿范围
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
 
The journal welcomes manuscripts in the following broad areas of research:

Cell and molecular biology including all aspects of tumor biology from a molecular and cellular point of view. Topics of interest include animal models, hypoxia, angiogenesis, metastasis, cellular signaling, cancer stem cells, DNA damage and repair, cell cycle and apoptosis.
Biomarker studies we will publish studies of diagnostic and prognostic markers which may ultimately be applicable in a clinical setting.  Submissions need to be REMARK compliant as established in NCI-EORTC's "Reporting Recommendations for Tumor Marker Prognostic Studies" (J Clin Oncol 23:9067, 2005) and "Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration" (J Natl Cancer Inst . 2018 Aug 1;110(8):803-811.).  They should report biomarkers that have a clear biologic relevance to a particular tumor type and be validated in at least one independent validation cohort and with biological validation in vitro or in vivo. Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation will not be considered at BMC Cancer.
Cancer epidemiology related cancer research including all aspects of cancer epidemiology including risk factors for disease initiation and development, social determinants, environmental, behavioural, and occupational correlates.
Experimental therapeutics and drug development including all aspects of preclinical investigations on therapeutic agents. It welcomes submissions concerning anti-cancer drug discovery and development, and targeted therapies.
Genetics, genomics and epigenetics including all aspects of genome-scale analysis, functional genomics, genetic association studies, pharmacogenomics and epigenetics in relation to cancer biology, diagnosis and therapy.
Tumour immunology including on all aspects of infectious agents associated with cancer and tumor immunology. Topics of interest include, but are not limited to, tumor immunity, immunotherapy, cancer vaccines, viral carcinogenesis and virus-host interactions.
Therapy studies with focus on clinical research that impacts on the treatment of cancer using systemic chemotherapy, immunotherappy, targeted therapy, and radiation. We further welcome submissions on research looking at therapy resistance mechanisms.
Surgical oncology with focus on clinical research that impacts on the diagnosis and treatment of cancer using surgery, diagnostic imaging, interventional therapeutics, and surgical pathology.
Systems biology, post-genomic analysis and emerging technologies including all all aspects of the function of biological systems at the molecular and cellular level, in particular those addressing network modeling, quantitative analyses and the integration of different levels of information. Topics of interest include, but are not limited to, deep sequencing-based technologies, computational biology and machine learning in relation to cancer biology.
Last updated: November 2021

BMC Cancer does not make editorial decisions on the basis of the interest of a study or its likely impact. Studies must be scientifically valid; for research articles this includes a scientifically sound research question, the use of suitable methods and analysis, and following community-agreed standards relevant to the research field.
收录体裁
Research article
Technical advance article
Database article
Software article
Study protocol
Review
投稿指南 https://bmccancer.biomedcentral.com/submission-guidelines
投稿模板 https://bmccancer.biomedcentral.com/submission-guidelines/preparing-your-manuscript
参考文献格式 https://bmccancer.biomedcentral.com/submission-guidelines/preparing-your-manuscript
编辑信息

Editor

Linda GummlichBMC Series, London, UK

Assistant Editors

Catherine Rice, Senior Assistant Editor, BMC Series, London
William Spenceley Jones, Assistant Editor, BMC Series, London

Consulting Editors
Yanis BoumberFox Chase Cancer Center, USA
Ken HerrmannUniversitätsklinikum Essen, Germany
Alan LeforJichi Medical University, Japan
Christophe NicotKansas University Medical Center, USA
Stephen PovoskiThe Ohio State University, USA
Dirk Vordermark, Martin Luther University Halle-Wittenberg, Germany

Associate Editors
Sherif Abdelhamed, St Jude Children’s Research Hospital, USA
Patriciu Achimas-Cadariu, Iuliu llatieganu University of Medicine and Pharmacy, Romania
Shailesh Advani, Georgetown University, USA 
Doreen Agnese, The Ohio State University, USA 
Atif Ahmed, Children’s Mercy Hospitals and Clinics, USA
Syed Ahmad, The University of Cincinnati Medical Center, USA
Sung Gwe Ahn, Yonsei, University College of Medicine, Korea, Republic of
Mohammad Reza Akbari, Women’s College Hospital, Canada
Domenico Albano, University of Brescia and Spedali Civili Brescia, Italy
Stefano Amatori, University of Urbino ‘Carlo Bo’, Italy
Laura Annaratone, University of Turin, Italy
Christina Annunziata, National Cancer Institute, USA
Takaaki Arigami, Kagoshima University Graduate School of Medical and Dental Sciences, Japan
Guillermo N. Armaiz-Pena, University of Texas MD Anderson Cancer Center, USA
Mary E. Aronow, Massachusetts Eye and Ear Infirmary, Harvard Medical School, USA
Sanjeevani Arora, Fox Chase Cancer Center, USA
Tetsuhiko Asao, Juntendo University, Japan
Hassan Ashktorab, Howard University, USA
Djordje Atanackovic, University of Utah, USA
Asfar Azmi, Wayne State University, USA
Duc-Hiep Bach, MD Anderson Cancer Center, USA
Floor Backes, Ohio State University, USA
Sunil Badve, Indiana University, USA
Insoo Bae, Lombardi Comprehensive Cancer Center, Georgetown University, USA 
Andrei Bakin, Roswell Park Comprehensive Cancer Center, USA
Fátima Baltazar, University of Minho, Portugal
Ramesh Balusu, University of Kansas Medical Center, USA                                 
Oluwaseun Adebayo Bamodu, Taipei Medical University, Taiwan
Sushanta Banerjee, University of Kansas Medical Center and VA Medical Center, USA
Ludovic Barault, University of Turin, Italy
Amorette Barber, Longwood University, USA
Joseph Barbi, Roswell Park Cancer Institute, USA
Nuno L Barbosa-Morais, Instituto de Medicina Molecular, Portugal
Tim Beck, Cleveland Clinic, USA
Jürgen Becker, Translational Skin Cancer Research, Germany
Andrzej K Bednarek, Medical University of Lodz, Poland
Tim Beissbarth, University Medical Center Göttingen, Germany
Antonino Belfiore, University, Policlinico Mater Domini, Italy
Marcia Bellon, University of Kansas Medical Center, USA
Adam Berger, Rutgers Cancer Institute of New Jersey, USA
Kishor K Bhakat, University of Nebraska Medical Center, USA
Souparno Bhattacharya, UT Southwestern Medical Center, USA 
Hemant Kumar Bid, Nationwide Children's Hospital, USA
Vincent Biron, University of Alberta Hospital, USA
Tarek Bismar, University of Calgary, Canada
Marc Bjurlin, New York University, USA
Giovanni Blandino, Italian National Cancer Institute Regina Elenalick, Italy
Josip Blonder, Frederick National Laboratory or Cancer Research, NCI at Frederick, Maryland USA
Michael Blumenfeld, Ohio State University, USA
Laura Bonanno, Istituto Oncologico Veneto IOV IRCCS, Italy
Luisa Borrell, Lehman College - CUNY, USA
Paige Bracci, University of California, USA
Hassan Brim, Howard University, USA
Mireille M.J. Broeders, Radboud University Nijmegen Medical Centre, Netherlands
Lodewijk Brosens, UMC Utrecht, Netherlands
Jean-Phillipe Brosseau, University of Texas Southwestern Medical Center, USA
Björn Brücher, Bon Secours Cancer Institute, USA
Adam Brufsky, University of Pittsburgh School of Medicine, USA
Jan Budczies, Charité - Berlin, Germany
Emily Burger, Harvard T.H. Chan School of Public Health, USA
Hakan Buyukhatipoglu, Harran University School of Medicine, Turkey
Abdelbaset Buhmeida, King Abdul-Aziz University, Saudi Arabia
Maurizio Callari, University of Cambridge, UK
Ernest Ramsay Camp, Medical University of South Carolina, USA
Dedong Cao, Wuhan University, China
Amancio Carnero, IBIS/ HUVR, CSIC, Spain
Darren Carpizo, Rutgers Cancer Institute of New Jersey, USA
Claudia Cardone, Università degli Studi Luigi Vanvitelli, Italy
Dirce Maria Carraro, AC Camargo Cancer Center, Brazil
Beatriz Carvalho, Netherlands Cancer Institute, Netherlands
Ignacio Casal, Centro de Investigaciones Biológicas, Spain
Colleen Cebulla, The Ohio State University, USA
Esteban Celis, H. Lee Moffitt Cancer Center, USA
Alessandra Ceolin, Schmitt Emory University Hospitals, USA
Anindita Chakrabarty, Shiv Nadar University, India
Nalini Chandar, Midwestern University, USA
Wen-Wei Chang, Chung Shan Medical University, Taiwan
Sanjib Chaudhary, University of Nebraska Medical Center, USA
Swapna Chaudhuri, School of Tropical Medicine, India 
Magdalena Chechlinska, Cancer Centre and Institute of Oncology, Poland
Xin Chen, University of California San Francisco (UCSF), USA
Chien-Chih Chiu, Koahsiung Medical University, Taiwan
William Cho, Queen Elizabeth Hospital, Hong Kong
Michal Chovanec, National Cancer Institute, Slovakia
Carlos Ciudad, School of Pharmacy, University of Barcelona, Spain
Stephen Clarke, University of Sydney, Australia
William B Coleman, University of North Carolina School of Medicine, Chapel Hill, USA
Rivka Colen, MD Anderson Cancer Center, USA
Lena-Christin Conradi, University Medical Center Göttingen, Germany
Jorge Cortes, MD Anderson Cancer Center, USA
Thomas P Conrad, University of Pittsburgh Cancer Institute, USA
Nils Cordes, Center for Radiation Research in Oncology (OncoRay), Dresden, Germany
Joanna Costello, University of Pittsburgh Medical Center, Physician Services Division, USA
Judy S Crabtree, LSU Health New Orleans, USA
Guanglin Cui, Nord University/Zhengzhou University, Norway/China
Zhaolei Cui, Fujian Medical University Cancer Hospital, China
Julie Cunningham, Mayo clinic, Laboratory Medicine and Pathology, USA
Margaret Currie, University of Otago Christchurch, New Zealand
Maria Grazia Daidone, Istituto Nazionale Tumori, Italy
Yataro Daigo, Institute of Medical Science, University of Tokyo, Japan
Siamak Daneshmand, USC/Norris Comprehensive Cancer Center, USA
Edoardo D’Angelo, University of Padova, Italy
Shabbar Danish, Rutgers Cancer Institute, USA
Bhudev Das, University of Delhi, India
Jürgen Debus, RadiationOncology, University Hospital Heidelberg, Germany
Scott Dehm, Mayo Clinic, USA
Elizabeth Dennett, Otago University, New Zealand
Deandreis Desiree, University of Turin, Italy
Sean Devlin, Memorial Sloan-Kettering Cancer Center, USA
Haryana Dhillon, The University of Sydney, Australia
José Díaz-Chávez, Instituto Nacional de Cancerología, México
Christina Dieli-Conwright, City of Hope National Medical Center, USA
Giuseppe Di Lorenzo, University Federico II, Italy
Ashokkumar Dilly, University of Pittsburgh, USA
Federica Di Nicolantonio, IRCC - University of Turin Medical School, Italy
Mehdi Djekidel, Yale University School of Medicine, USA
Susan Domchek, University of Pennsylvania, USA
Amy Downing, University of Leeds, UK
Marciana Nona Duma, Klinikum rechts der Isar, TU München, Germany
Barbara Dunn, NIH/NCI/Division of Cancer Prevention, USA
Peter Dziegielewski, University of Florida, USA
Joanne Edwards, University of Glasgow, UK
Eyad Elkord, University of Salford, UK
Mara Epstein, University of Massachusetts Medical School, USA
Francesco Fanfani, Catholic University, Italy
Hezhi Fang, Wenzhou Medical University, China
Pietro Di Fazio, Philipps University Marburg, Germany
Wolfgang Fendler, Klinikum der Universität München
Gustavo Dos Santos Fernandes, Hospital Sírio-Libanês, Brazil
Mary Jo Fidler, Rush University, USA 
Michael Folkert, UT Southwestern Medical Center, USA
Paul Foster, University of Birmingham, UK
Robert Fruscio, San Gerardo Hospital, Italy
Siqing Fu, M.D. Anderson Cancer Center, USA
Yutaka Fujiwara, Cancer Center, Japan 
Hideki Furuya, Cedars Sinai Medical Center, USA
Nicola Fusco, University of Milan, Italy
Juehua Gao, University Feinberg School of Medicine, USA
Adam Garsa, University of Southern California, United States
Yubin Ge, Wayne State University School of Medicine, USA
Timo Gemoll, University of Lübeck, Germany
Armin Gerger, Division of Clinical Oncology, Research Unit Genetic, Austria
Gargi Ghosal, University of Nebraska Medical Centre, USA
Arnab Ghosh, Memorial Sloan Kettering Cancer Center, USA
Spencer B Gibson, University of Manitoba, Canada
Elisa Giovannetti, VU University Medical Center, Netherlands
Vincent Gnanapragasam, Department of Oncology, University of Cambridge, UK
Erica Golemis, Fox Chase Cancer Center, USA
Erin Grady, Emory University School of Medicine, USA
Steven Gray, St James’s Hospital, Ireland
Giovanni Grignani, Candiolo Cancer Institute-FPO- IRCCS, Italy
Valerie Grignol, The Ohio State University, USA
Jeffery Groce, The Ohio State University, USA
Alejandro Gru, University of Virginia, USA
Elia Guadagno, Università degli Studi di Napoli Federico II, Italy
Emer Guinan, Trinity College Dublin, Ireland
Rama Gullapalli, University of New Mexico, USA
Zong Sheng Guo, University of Pittsburgh, USA
Digant Gupta, Cancer Treatment Centers of America, USA
Nathan C Hall, The Hospital of the University of Pennsylvania, USA
Yasuo Hamamoto, Keio University School of Medicine, Japan
Chisato Hamashima, National Cancer Center, Japan
Sun-Young Han, Gyeongsang National University, South Korea
Arndt Hartmann, Institute of Pathology, Erlangen, Germany
Matthias G Hautmann, University Hospital Regensburg, Germany 
Jeffrey Hawley, Wexner Medical Center at the Ohio State University, USA
John Hays, The Ohio State University James Cancer Center, USA
Khalil Helou, Gothenburg University, Sweden
Mieke Van Hemelrijck, King's College London, UK
Brittney-Shea Herbert, Indiana University School of Medicine, USA
Shawn Hervey-Jumper, University of Michigan, USA
Arnold Hill, Royal College of Surgeons in Ireland, Ireland
Robert Hines, University of Central Florida College of Medicine, USA
Kenji Hirata, Hokkaido University, Japan
Stefan Holdenrieder, University Hospital Bonn, Germany
Adilia Hormigo, School of Medicine at Mount Sinai, USA
Hsin-An Hou, NTU Hospital, Taiwan
Ying-Yong Hou, Zhongshan Hospital, Fudan University, China
Andrew Hoy, University of Sydney, Australia
Michael Hummel, Charité - Berlin, Germany
Deema Hussein, King Abdulaziz University, Saudi Arabia
Milena Ilic, University Kragujevac, Serbia 
Ciro Isidoro, Universita del Piemonte Orientale, Italy
Salma Jabbour, Rutgers Cancer Institute of New Jersey, Rutgers University, Robert Wood Johnson Medical School, USA
Frank Jansman, University Groningen, Netherlands
Stefan Janssen, University of Lübeck, Department of Radiation Oncology, Germany
Carmen L Jeronimo, IPO-Porto & ICBAS-University of Porto, Portugal
Wei Jiang, Thomas Jefferson University, USA
Moonsoo M. Jin, Weill Cornell Medical College, USA
Andreas Jung, Ludwig-Maximilians Universität München, Germany
Benjamin H Kaffenberger, Ohio State University Wexner Medical Center, USA
Jagat Kanwar, Deakin University, Australia
Sophia N Karagiannis, King's College London, UK
Omer Faruk Karatas, Erzurum Technical University, Turkiye
Kinyas Kartal, Koc University, Turkey
Fatah Kashanchi, George Washington University, USA
Manoj Kashyap, Amity University Haryana, India
Bhumsuk Keam, Seoul National University Hospital, Republic of Korea
Volker Van Kemenade, Erasmus Uni Med Center, Netherlands
Betty Y.S. Kim, Mayo Clinic Florida, USA
Tae Sung Kim, School of Life Sciences & Biotechnology, South Korea
Roman Kloeckner, University Medical Center of the Johannes Gutenberg-University Mainz, Germany
Matthias Kloor, University of Heidelberg, Germany
Kemal Kosemehmetoglu, Hacettepe University, Turkey
Joanne Kotsopoulos, Women’s College Research Institute, Women’s College Hospital, Canada
Artur Kowalik, Holycross Cancer Center, Poland
Somashekar Krishna, The Ohio State University Medical Center, USA
Sebastian Krug, Martin-Luther Universität Halle/Wittenberg, Germany
Arutha Kulasinghe, Queensland University of Technology, Australia
Rahul Kumer, Iriving Medical Center, Columbia University, USA
Hidekazu Kuramochi, Tokyo Women's Medical University, Japan
Özgür Kutuk, Baskent University, Turkey
Sjoerd Lagarde, Erasmus MC, University Medical Centre, Netherlands
Rosamaria Lappano, University of Calabria, Italy
Anne Laprie, IUCT-oncopole, France
Rossano Lattanzio, “G. d’Annunzio” University – Center for Advanced Studies and Technology (CAST), Italy
Marianna Lauricella, University of Palermo, Italy
Maxwell P Lee, National Cancer Institute, USA
Maciej Lesniak, The University of Chicago, USA
Charles LeVea, Roswell Park Cancer Institute, USA
Zaibo Li, Ohio State University Wexner Medical Center, USA
Priya Londhe, Tufts Medical Center, USA
Herbert Loong, The Chinese University of Hong Kong, Hong Kong SAR
Ian Lorimer, Ottawa Hospital Research Institute, Canada
Alessandro Lugli, University of Bern, Switzerland
Katharina Lückerath, Universität Würzburg, Germany
Tim Luetkens, University of Utaj, USA
Kiven Erique Lukong, University of Saskatchewan, Canada
Cathy Ma, University of Pittsburgh Medical Center, USA
Anant Madabhushi, Case Western Reserve University, USA
Andrea Mafficini, University and Hospital Trust of Verona, Italy
Marcello Maggiolini, University of Calabria, Italy 
David Malkin, The Hospital for Sick Children, Canada
Judith Malmgren, University of Washington and HealthStat Consulting Inc., USA
Joshua Mammen, University of Kansas, USA
Chandi C. Mandal, Central University of Rajasthan, India
Vishnu R Mani, Columbia University College of Physicians and Surgeons at Harlem Hospital Center, USA
Jonas Manjer, Dept. of Clinical Sciences Malmö, Surgery, Sweden
Luigi Marano, University of Siena, Italy
Vitaly Margulis, The University of Texas Southwestern Medical Center, USA
Florian Markowetz, Cancer Research UK, UK
Angela Marten, University of Heidelberg, Germany
Maurizio Martini, Università Cattolica del Sacro Cuore, Italy
Ashiq Masood, Saint Luke's Cancer Institute, University of Missouri-Kansas City School of Medicine, USA 
Khalid Matalka, OncoTherapeutica, Inc., USA
Fabrizio Mattei, Istituto Superiore di Sanità, Italy 
Georgia Mavria, University of Leeds, UK
Anne May, University Medical Center Utrecht, Netherlands
Antonio Mazzocca, University of Bari Medical School, Italy                                                
Michal Mego, Comenius University, Medical Faculty, Slovakia
Markus Meissner, Goethe University Frankfurt, Germany
Úna Mc Menamin, Queen’s University Belfast, United Kingdom
Qing Meng, The University of Texas MD Anderson Cancer Center, USA
Eric Metzen, University of Duisburg-Essen, Germany
Michael Michael, Peter MacCallum Cancer Centre, Australia
Sandip Mishra, Institute of Life Sciences, India 
Makito Miyake, Nara Medical University, Japan
Markus Moehler, University of Mainz, Germany
Ramzi Mohammad, Wayne State University, USA
Manuel A. Molina, Lakeland Regional Cancer Center, USA
Andrea Morandi, University of Florence, Italy 
Mikito Mori, International University of Health and Welfare Ichikawa Hospital, Japan
Naoshad Muhammad, Washington University in Saint Louis, USA
Michael Murders, Rudolf-Becker-Laboratory for Translational Prostate Cancer Research, Institute of Pathology, University of Bonn Medical Center, Germany
Tomoki Nakamura, Mie University, Japan
Kentaro Nakayama, Shimane University, Japan
Tomio Nakayama, National Cancer Institute, Japan
Jens Neumann, Ludwig-Maximilians-Universität München, Germany
Sisse Helle Njor, Department of Public Health Programmes, Denmark
Bo Nordman, Erasmus MC, University Medical Centre, Netherlands 
Nicola Normanno, ITN-Fondazione Pascale, Italy 
George Notas, University of Crete School of Medicine, Greece
Naoki Oishi, University of Yamanashi, Japan
Cem Onal, Baskent University Faculty of Medicine, Turkey
Josep Oriola, University of Barcelona, Spain 
Christian Ostheimer, Martin Luther University Halle-Wittenberg, Germany
Medhi Ouaïssi, Trousseau Hospital, France
Young-Ki Paik, Yonsei University, South Korea 
Frank Pajonk, University of California San Francisco (UCLA), USA
Nallasivam Palanisamy, Henry Ford Health System, USA
Dario Palmieri, The Ohio State University, USA
Manoj Pandey, Penn Stat Hershey Medical Center, USA
Cédric Panje, Kantonsspital St. Gallen, Switzerland
Maria Abbondanza Pantaleo, Univesity of Bologna, Italy
Deepak Parashar, Medical College of Wisconsin, USA
Jae-Il Park, University of Texas MD Anderson Cancer Center, USA
James Park, University of Glasgow, UK
Vinita Parkash, Yale University School of Medicine, USA
Christopher Parker, Institute of Cancer Research, UK
Toshima Parris, University of Gothenburg, Sweden
Akash Patel, Baylor College of Medicine, USA 
Jijo Paul, Medical College of Wisconsin, USA
Marco Pellegrini, Consiglio Nazionale delle Ricerche, Italy
Chun-Wei Peng, Hubei Key Laboratory of Tumor Biological behaviors & Hubei Cancer, China
Gao Peng, The First Hospital of China Medical University, China
Arjun Pennathur, University of Pittsburgh Medical Centre, USA
Manuel Perucho, The Burnham Institute, USA
Stefano Petti, Sapienza University, Italy
Georg Pfeiler, Medical University of Vienna, Austria
Roberto Pippi, Sapienza University of Rome, Italy
Giuseppe Pirozzi, National Cancer Institute, Italy
Kamal S Pohar, Ohio State University, USA
Stephan Polterauer, Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria
Sima Porten, University of California, San Francisco, USA 
George A. Poultsides, Stanford University, USA
Juan Poyatos, Spanish National Research Council (CSIC), Spain
Joseph Pressey, Cincinnati Children’s Hospital Medical Center, USA
Daniel Prevedello, The Ohio State University Medical Center, USA
Alessandro Provenzani, CIBIO, University of Trento, Italy
Gillian Prue, Queen’s University Belfast, Northern Ireland
Sarah Psutka, John H. Stroger Hospital of Cook County, USA
Joan-Anton Puig, Hospital Clinic de Barcelona, Spain
Kristen Purrington, Wayne State University School of Medicine, USA
Yuliya Pylayeva-Gupta, University of North Carolina at Chapel Hill, USA
Ya-Wei Qiang, University of Arkansas for Medical Sciences, USA
Liang Qiao, University of Sydney, Australia
Dirk Rades, University Hospital Schleswig-Holstein, Germany
Dan Raz, City of Hope Medical Center, USA
Matejka Rebolj, University of Copenhagen, Denmark
Alaa Refaat, National University of Ireland Galway, Ireland
Alistair Reid, Imperial College London, UK
Daniel Reim, TUM School of Medicine,, Germany
Günther Rezniczek, Ruhr-Universität Bochum, Germany
Debra Richardson, University of Texas Southwestern Medical Center, USA
Brian Robinson, New York Presbyterian Hospital, USA
Carla Rohrer, Bley Vetsuisse Faculty, University of Zurich, Switzerland
Stefano Rosso, Registro Tumori Piemonte, Italy
Dimitrios Roukos, Ioannina University, Greece
Eugen Ruckhaberle, Dept. Gyn, OB Duesseldorf
Charles Rudin, Johns Hopkins University, USA
Oscar M Rueda, Cancer Research UK, UK
Joern Ruessel, University Hospital Halle (Saale), Germany
Thomas Ruhstaller, Cantonal Hospital of St. Gallen, Switzerland
Annamaria Ruzzo, University of Urbino, Italy
Morten Rye, Norweigian University of Science and Technology, Norway
Renaud Sabatier, Institut Paoli Clamettes, France
Biswarup Saha, H Lee Moffitt Cancer Center & Research Institute, USA
Özgür Sahin, University of South Carolina, USA
Yasunaru Sakuma, Jichi Medical Unversity, Japan
Nader Sanai, Barrow Brain Tumor Research Center/Arizona State University, USA
Dipak Sapkota, University of Oslo, Norway
Gangadhara Reddy Sareddy, University of Texas, USA
Andrea Sartore-Bianchi, Grande Ospedale Metropolitano Niguarda, Italy
Sharon Savage, DCEG, NCI, NIH, USA
Douglas Sborov, University of Utah, Huntsman Cancer Institute, USA
Matthew B Schabath, H. Lee Moffitt Cancer Center and Research Institute, USA
Tom Scharschmidt, Ohio State University, USA
Eva Schernhammer, Brigham and Women's Hospital and Harvard Medical School, USA
Fernando Schmitt, IPATIMUP - University of Porto, Portugal
Anne F Schott, University of Michigan, USA
Laura Sciacca, University of Catania, Italy
Gautam Sethi, National University of Singapore, Singapore
Noula Shembade, University of Miami, USA
Lin Shen, Peking University Cancer Hospital & Institute, China
Aesun Shin, Seoul National University, South Korea
Mark Shiroishi, USC, USA   
Stuti Shroff, University of Pennsylvania, USA
Ting Si,  University of Science and Technology of China, China
Rana Singh, Jawaharlal Nehru University, India 
Shree Ram Singh, National Cancer Institute, USA
Diego Sisci, University of Calabria, Italy
Shivan Sivakumar, University of Oxford, UK
Szymon Skoczen, Jagiellonian University Medical  College, Poland
Alexandra Smith, University of York, UK
Robert Smith, University of Hong Kong, Hong Kong
Ponnandai Somasundar, Roger Williams Medical Center, USA
Erwei Song, Sun Yat-Sen University, China 
Hugo Sousa, IPO Porto FG, EPE, Portugal
Jeremy Squire, University of Sao Paulo, Brazil
Eric Steiner, GPR Clinical Centre, Germany
Lucia Anna Stivala, University of Pavia, Italy
Oliver Stoeltzing, Helios Klinikum Berlin-Buch, Germany
Shih-Chi Su, Chang Gung Memorial Hospital, Taiwan
Chitra Subramanian, University of Michigan, USA
Ruping Sun, University of Minnesota, USA
Shi-Yong Sun, Emory University, USA
Debasish Sundi, The University of Texas, USA
Bret Taback, Columbia University Medical Center, USA
Namiatsu Takahara, University of Tokyo Hospital, Japan
Motoyoshi Tanaka, Chugai Pharmaceutical Co., Ltd., Japan
Xiuwen Tang, Zhejiang University School of Medicine, China
Yongguang Tao, Cancer Research Institute of Central South University, China
Clayton Taylor, The Ohio State University Wexner Medical Center, USA 
Alicia M Terando, The Ohio State University, USA 
Charles C Theillet, INSERM Montpellier, France
John Timms, University College London, UK
Marieta Toma, University Clinic Bonn, Germany
Bastiaan Tops, Prinses Maxima Centrum, Netherlands
Gary Tozbikian, The Ohio State University Wexner Medical Center, USA
Nham Tran, University of Technology Sydney, Australia
Melissa Troester, University of North Carolina at Chapel Hill, USA
Caroline Vandeputte, Jules Bordet Institute, Belgium
Kate Vandyke, University of Adelaide, Australia
Paul van Diest, UMC Utrecht, Netherlands
Athanassios Vassilopoulos, Northwestern University, USA
Omkara Lakshmi Veeranki, University of Texas, USA
Massimiliano Veroux, University Hospital of Catania, Italy 
Renata Veselska, Masaryk University, Czech Republic
Erina Vlashi, UCLA College of Life Sciences, USA
Ulla Vogel, National Research Centre for the Working Environment, Denmark
Kay-Uwe Wagner, University of Nebraska Medical Center, USA
Sébastien Wälchli, Oslo Cancer Cluster Incubator, Norway
Andrew Wang, UNC Chapel Hill, USA
Cheng-Ping Wang, National Taiwan University Hospital, UK
Hua Wang, Rockefeller Research Labs (MSK), USA
Yong Wang, Academy of Mathematics and Systems Science, China
Xuefeng Wang, H. Lee Moffitt Cancer Center & Research Institute, USA
Zhanwei Wang, University of Hawaii Cancer Center, USA
Zhen-Ning Wang, The First Hospital of China Medical University, China
Sudha Warrier, Manipal Academy of Higher Education, India
Cheryl Watson, University of Texas Medical Branch, USA
Jia Wei, Affiliated Drum Tower Hospital to Medical School of Nanjing University, China
Qiou Wei, University of Kentucky College of Medicine, USA
Michael Weichenthal, University of Kiel, Germany 
Hannah Wen, Memorial Sloan-Kettering Cancer Center, USA
Armin Wiegering, University Hospital of Wuerzburg, Germany
Joachim Widder, Medical University of Vienna, Austria
Stefan M Willems, UMC Utrecht, Netherlands
John Williams, University of Chester, UK
Robert Winqvist, University of Oulu, Finland
Licun Wu, Toronto General Hospital, University Health Network, Canada
Shuai Wu, The Wistar Institute, USA
Wa Xian, UT Health, USA
Jie Xu, Fudan University, China 
Vasily Yakolov, VCU Massey Cancer Center, USA
Hiroharu Yamashita, Graduate School of Medicine, The University of Tokyo, Japan
Shun-Fa Yang, Chung Shan Medical University, Taiwan
Sang-Kyu Ye, Seoul National University, Korea
John Yim, Beckman Research Institute of City of Hope, USA
Akira Yoshida, International University of Health and Welfare, Japan
George Yousef, St. Michael's Hospital, Canada
Kenneth Yu, Memorial Sloan Kettering Cancer Center, USA
Chae-Ok Yun, Yonsei University College of Medicine, South Korea 
Peter Zage, University of California San Diego, USA
Dani Zander, Penn State College of Medicine, USA
Youssef Zeidan, American University of Beirut, Lebanon
Ling Zhang, Moffitt Cancer Center, USA 
Shiwu Zhang, University of Science and Technology of China, China
Tian Zhang, Duke University, USA
Xian Zhang, Memorial Sloan-Kettering Cancer Center, USA
Xiaotian Zhang, Peking University Cancer Hospital, China
Hua Zhao, M.D. Anderson Cancer Center, USA
Hua-chuan Zheng, China Medical University, China
Yuanyi Zheng, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, China
Jiaan Zhu, Beijing University/Peking University, China
Emanuele Zucca, Oncology Institute of Southern Switzerland, Switzerland
Debra Zynger, The Ohio State University Medical Center, USA

Editorial Advisors
Mariano Barbacid, Centro Nacional de Investigaciones Oncologicas, Spain
Frederick A Beland, National Center for Toxicological Research, USA
Andrew Bergen, SRI International, USA
Anton Berns, Netherlands Cancer Institute, Netherlands
Maria Blasco, Spanish National Cancer Institute Madrid, Spain
Burkhard Brandt, Universitätsklinikum Hamburg-Eppendorf, Germany
Joan S Brugge, Harvard University, USA
Lewis Cantley, Harvard Institutes of Medicine, USA
Seth J Corey, Northwestern University, USA
Jack Cuzick, Queen Mary's School of Medicine and Dentistry, UK
Shoukat Dedhar, BC Cancer Agency, Canada
Susan Domchek, University of Pennsylvania, USA
William Gallagher, UCD Conway Institute, University College Dublin, Ireland
Paul A Edwards, Cambridge University, UK
Matthew Ellis, Washington University in St. Louis, USA
Gerard Evan, University of California, USA
Ian Frazer, University of Queensland, Australia
Henry S Friedman, Duke University Medical Center, USA
Gustav Gaudernack, The Norwegian Radium Hospital, University of Oslo, Norway
John A Hartley, University College London, UK
Nick Hastie, Western General Hospital, UK
Toshio Hirano, Osaka University Graduate School of Medicine, Japan
Ahmedin Jemal, American Cancer Society, USA
Christopher Kane, Pfizer Inc., USA
Karla Kerlikowske, University of California, USA
Peter Lansdorp, British Columbia Cancer Agency, Canada
Ralph J Lelle, Muenster University, Germany
Michael C MacLeod, University of Texas/ M.D. Anderson Cancer Center, USA
Frank McCormick, University of California, USA
Linda Z Penn, Princess Margaret Hospital, Ontario Cancer Institute, Canada
Jerome Posner, Memorial Sloan-Kettering Cancer Center, USA
Kathy Pritchard-Jones, Royal Marsden Hospital & Institute of Cancer Research, UK
William Rom, New York University School of Medicine, USA
Darryl Shibata, Keck School of Medicine, University of Southern Carolina, USA
Raj Srirajaskanthan, Kings College Hospital, UK
Steven D Stellman, Mailman School of Public Health, Columbia University, USA
David Stokoe, University of California, USA
Barbara Vanderhyden, University of Ottawa, Canada
Andrew Vickers, Memorial Sloan-Kettering Cancer Center, USA
Satish Viswanath, Case Western Reserve University, USA
Frederic M Waldman, University of California, USA
Denys Wheatley, BioMedES, UK
Susie Wilkinson, Royal Free & University College Medical School, UK
James Woodgett, Samuel Lunenfeld Research Institute, Canada 
Pengcheng Xun, Indiana University, USA

Statistical Advisors
Noori Akhtar-Danesh, McMaster University, Canada
Marisa  Baré, Institut Universitari Parc Taulí, Spain
Guy Brock, University of Louisville, USA
Justin C Brown, Dana-Farber Cancer Institute, USA
Marinela Capanu, Memorial Sloan Kettering Cancer Center, USA
Magdalena Castro Cruz, Clínica las Condes, Chile
Kumardeep Chaudhary, Icahn School of Medicine at Mount Sinai - New York City, NY, USA
Leslie Cope, Johns Hopkins University, USA
Giuliana Cortese, University of Padova, Italy
Feng Gao, Washington University School of Medicine, USA
Sophie Gourgou, Institut Regional du Cancer, France
Chindo Hicks, University of Mississippi Medical Center, USA
YenYi Ho, University of Minnesota, USA
Peng Huang, Johns Hopkins Medicine, USA
John Hughes, UK
George A. Kelley, West Virginia University, USA
Sungjin Kim, Cedars-Sinai, USA
Caroline Mollevi, Institut du Cancer de Montpellier, France
John Frederick Pearson, University of Otago, New Zealand
Cielito C Reyes-Gibby, University of Texas MD Anderson Cancer Center, USA
Alex Sánchez-Pla, University of Barcelona, Spain
Brent Jay Shelton, University of Kentucky College of Public Health, USA
Jin-ah Sim, St. Jude Children’s Research Hospital, USA
Rainer Spang, Universität Regensburg, Germany
Christopher Stevenson, Deakin University, Australia
Elizabeth A Sugar, Johns Hopkins Bloomberg School of Public Health, USA
Dawen Sui, The University of Texas MD Anderson Cancer Center, USA
Matthew Truong, University of Rochester, USA
Hao Wang, Johns Hopkins Medicine, USA
Wenyi Wang, The University of Texas MD Anderson Cancer Center, USA 

我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug